Remedio

Network Management Software · Tel Aviv, Israel · Founded 2017 · Privately Held (backing)

Operator of a cybersecurity company intended to help organizations identify problems with their group policy objects (GPOs). Remedio is based in Tel Aviv, Israel and was founded in 2017. It was valued at $215 million at its later-stage round in Sep 2025, the last priced event on record. It has raised $65 million across 1 recorded round; the latest was a $65 million later-stage round in Sep 2025.

PMV mark · valuation
$214.6M
Oct 2026
Priced at
its later-stage round
Sep 2025
Total raised
$65.0M
Last round
Later Stage VC
Sep 2025
What is Remedio worth?
$214.6MPrivateMarketView mark · Oct 2026

Valued at $214.6M at its later-stage round, Sep 2025. Nothing has traded since.

Free account
More of Remedio with a free account
  • ·Watch Remedio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Remedio funding history

1 rounds
DateRoundRaisedPost-money
Sep 2025Later Stage VC$65.0M▮
Unlock post-money valuations

Membership and data by Private Market View

Remedio valuation

Remedio was valued at $215 million at its later-stage round in Sep 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Remedio raised?

Remedio has raised $65 million across 1 recorded round since 2025. The largest was a $65 million later-stage round in Sep 2025.

Comparable companies

Comparable network management software names by valuation on PrivateMarketView: AttackIQ ($221 million), Oneleet ($215 million) and Sentra ($205 million).

How Remedio's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Remedio, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Remedio

What is Remedio worth?
Remedio is valued at $214.6M as of Oct 2026. Valued at $214.6M at its later-stage round, Sep 2025. Nothing has traded since.
How much has Remedio raised?
Remedio has raised $65.0M in total funding across 1 recorded rounds.
When did Remedio last raise?
Remedio last raised in Sep 2025 (Later Stage VC), raising $65.0M.